The efficacy and safety of reduced-dosage rituximab in the treatment of neuromyelitis optica spectrum disorders under B cell monitoring-A prospective study

LI Yuanyuan,YU Hai,WANG Xiaozhu,et al

Journal of Apoplexy and Nervous Diseases ›› 2021, Vol. 38 ›› Issue (4) : 345-348.

PDF(2158 KB)
PDF(2158 KB)
Journal of Apoplexy and Nervous Diseases ›› 2021, Vol. 38 ›› Issue (4) : 345-348. DOI: 10.19845/j.cnki.zfysjjbzz.2021.0088
J Apoplexy and Nervous Diseases

The efficacy and safety of reduced-dosage rituximab in the treatment of neuromyelitis optica spectrum disorders under B cell monitoring-A prospective study

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 38(4): 345-348 https://doi.org/10.19845/j.cnki.zfysjjbzz.2021.0088

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2158 KB)

Accesses

Citation

Detail

Sections
Recommended

/